Bill Gates-backed Ginkgo Bioworks going public via $15 billion SPAC By: CNBC.com News May 11, 2021 at 09:59 AM EDT Ginkgo Bioworks is going public via a merger with former MGM CEO Harry Sloan's SPAC in a deal that values the biotech company at $15 billion. Read More >> Related Stocks: Renaissance IPO ETF Renaissance International IPO ETF
